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Abstract
Aims/hypothesis Genome-wide association studies have
identified novel WHR and BMI susceptibility loci. The
aim of this study was to elucidate if any of these loci had an
effect on quantitative measures of glucose homeostasis,
including estimates of insulin release and insulin sensitivity
in an epidemiological setting.
Methods By applying an additive genetic model, 14 WHR-
associated gene variants and 18 BMI-associated variants
were investigated for their relationships with glucose-
related metabolic traits in treatment-naive individuals from
the population-based Inter99 study sample (n=6,039).
Results Of the variants associated with BMI, the QPCTL
rs2287019 C allele was associated with an increased
insulinogenic index of 7.4% per risk allele (p=4.0×10−7)
and increased disposition index of 5.6% (p=6.4×10−5). The
LRP1B rs2890652 C allele was associated with insulin
resistance, showing a 3.3% increase (p=0.0011) using the
HOMA-insulin resistance (HOMA-IR) index and a 2.2%
reduction (p=0.0014) with the Matsuda index. Of the variants
associated with WHR, LYPLAL1/SLC30A10 rs4846567 G
allele carriers showed a 5.2% lower HOMA-IR (p=0.00086)
in women, indicating improved insulin sensitivity. Female
carriers of the VEGFA rs6905288 A allele were insulin
resistant, with a 3.7% increase in HOMA-IR (p=0.00036)
and 4.0% decrease in Matsuda index (p=2×10−4).
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Conclusions Our correlative findings from analysing
single-locus data suggest that some variation in validated
BMI and WHR loci are associated with either increased or
decreased insulin sensitivity and thereby potentially with
metabolically healthy or metabolically unhealthy subsets of
obesity. The results call for testing in larger study samples
and for further physiological exploration of the possible
metabolic implications of these loci.
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Insulin secretion . Obesity .WHR
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Introduction
Although the epidemic nature of obesity may predom-
inantly be attributable to major changes in environmen-
tal factors for modern living, numerous genetic factors
are known to predispose to altered body composition,
including changes in BMI and WHR, both of which are
inherited traits, with heritability estimates for BMI of
h2 ∼40–70% and WHR of h2 ∼45% [1].
Since 2007, several genome-wide association studies
(GWAS) have identified a number of common variants that
are associated with BMI and WHR. Initially, variants in
FTO and MC4R were reported to be associated with BMI
[2, 3], and subsequent studies have revealed >50 loci
associated with various aspects of adiposity [1, 4, 5].
In 2010, two large GWAS meta-analyses from the
GIANT (Genetic Investigation of ANthropometric Traits)
consortium were published. Both studies conducted a
discovery stage analysing ∼2.8 million imputed and
genotyped single-nucleotide polymorphisms (SNPs). In a
study of BMI, 46 GWAS were meta-analysed including up
to 123,865 individuals, and 42 were genotyped in stage 2
including up to 125,931 individuals. This study revealed 18
novel loci associated with BMI showing effect sizes on
BMI of between 0.06 and 0.22 kg/m2 per risk allele [4]. A
parallel GIANT study investigated WHR adjusted for BMI
in GWAS data from 32 studies comprising 77,167
participants with replication in a further 113,636 samples
[5]. This study found 14 novel variants associated with
WHR at a genome-wide significance level, with β values
between 0.022 and 0.043 per change in WHR-increasing
allele. Sex-stratified analyses showed sex-specific effects,
as 12 of 14 SNPs reached genome-wide significance in
women and only three of 14 in men.
Given the hypothesis-free approach used in GWAS,
most of the identified loci have no known involvement
in pathogenesis of obesity or energy or glucose
metabolism. No obvious biological mechanisms were
identified for the BMI-associated variants; however, the
GIANT investigators reported evidence that the WHR-
associated loci may predominantly be associated with
developmental processes, suggesting an important influ-
ence on basal body fat distribution [6]. This is in contrast
with previous theories suggesting a major role for genes
associated with body composition in regulation of appetite
and energy expenditure [7–9].
Given the limited physiological knowledge of the biolog-
ical implications of the recent variants discovered by the
GIANT consortium, we aimed to elucidate in an epidemio-
logical setting some of the underlying metabolic phenotypes
of the 32 variants associated with either BMI or WHR, with a
focus on estimates of insulin release and insulin sensitivity.
Methods
Study population The 18 SNPs associated with BMI and 14
SNPs associated with WHR were genotyped in treatment-
naive individuals from the population-based Inter99 study
sample (n=6,039). Inter99 is a population-based, rando-
mised, non-pharmacological intervention study of middle-
aged individuals for the prevention of ischaemic heart
disease, who were recruited through the Research Centre
for Prevention and Health in Glostrup, Copenhagen (Clin-
icalTrials.gov ID-no: NCT00289237) [10]. The study partic-
ipants underwent a standard 75 g OGTT. Patients with type 2
diabetes, type 1 diabetes or diabetes as a consequence of
known chronic pancreatitis, haemochromatosis, mutations in
the insulin receptor, lipodystrophy, maturity-onset diabetes of
the young, maternally inherited diabetes and deafness, family
history of first-degree relatives with type 1 diabetes, insulin
requirement within the first year after diabetes diagnosis or a
fasting serum C-peptide level ≤150 pmol/l at the time of
recruitment were excluded from the study. All study
participants were Danes by self-report, and informed written
consent was obtained from all volunteers before participa-
tion. The study was approved by the regional ethics
committees, Copenhagen County, and was conducted in
accordance with the principles of the Helsinki Declaration.
Biochemical and anthropometric measures Body weight
and height were measured with the participants wearing
light indoor clothes and no shoes. BMI was defined as
weight in kilograms divided by height in metres squared
(kg/m2). Blood samples were drawn after a 12 h overnight
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fast. Plasma glucose was analysed by the glucose oxidase
method (Granutest; Merck, Darmstadt, Germany), and
serum insulin [excluding des(31, 32) and intact proinsulin]
was measured using the AutoDELFIA insulin kit (Perkin-
Elmer, Wallac, Turku, Finland). HOMA of insulin resis-
tance (HOMA-IR), an index of hepatic insulin resistance in
the fasting state, was calculated as (fasting plasma glucose
[mmol/l]×fasting serum insulin [pmol/l])/22.5 [11]. The
Matsuda index expressing whole-body insulin sensitivity
index was calculated as described previously [12]. Low
HOMA-IR and Matsuda index are associated with insulin
resistance. The insulinogenic index was calculated as
(serum insulin 30 min after OGTT [pmol/l]−fasting serum
insulin [pmol/l])/plasma glucose 30 min after OGTT
(mmol/l). The disposition index was calculated by multi-
plying the insulinogenic index and the Matsuda insulin
sensitivity index, relating beta cell function to ambient
insulin sensitivity. In addition, orally glucose-stimulated
insulin release was reported as the BIGTT-acute insulin
response (AIR) index. The BIGTT index applies informa-
tion on sex and BMI combined with plasma glucose and
serum insulin during an OGTT, to provide an index for
AIR, and was calculated as reported previously [13].
Statistical analysis To test quantitative traits for differences
between genotype groups, a general linear model was used,
applying additive models for each variant and including
adjustments for sex, age and with and without adjustment
for BMI. Analyses were also performed using recessive and
dominant models (see electronic supplementary material
[ESM] Tables 1–4). The variants previously shown to be
associated with WHR were also tested with adjustment for
WHR, but this did not alter the results. All analyses were
performed by RGui version 2.12.2 (R Development Core
Team [1999]). Given the number of SNPs tested, we
corrected for multiple testing with the Bonferroni correction
leading to a statistical significance threshold of 0.05/32=
0.0016. Associations with a p value <0.05 but >0.0016 were
considered to be nominally significant. All quantitative
measures were logarithmically transformed before analysis.
The specific traits examined were fasting plasma
glucose, fasting serum insulin, estimates of insulin
sensitivity (HOMA-IR and ISI Matsuda), estimates of
acute insulin response (BIGTT-AIR and insulinogenic
index) and disposition index. Because of the known
sexual dimorphism of WHR, analyses of variants
previously associated with WHR were performed com-
bined as well as for each sex. Interaction analyses were
performed (see ESM Table 5). However, after adjustment
for multiple testing, no significant interaction was found
for the variants previously shown to be associated with
WHR. Despite the lack of significant interactions, sex
stratification is included, given the well-known biological
sex differences of WHR. The sex-stratified analyses
included 3,004 men and 3,035 women.
Statistical power analysis Statistical power for quantita-
tive traits was estimated using simulations. An additive
genetic model was used for both the simulation of the
data and testing the data using a linear model. We used
the allele frequencies of the 18 variants associated with
BMI and 14 variants associated with WHR and a
sample size of 6,039 individuals to estimate the effect
size for each allele for which we had 80% statistical
power to detect an association in the given quantitative
trait. We carried out 5,000 simulations and applied a
significance threshold of 0.0016. We had 80% statistical
power to detect an allelic difference of 0.9–1.2% in
fasting plasma glucose, 4.3–5.7% in fasting serum
insulin, 4.6–6.1% in HOMA-IR, 4.4–5.8% in disposition
index, 3.1-4.1% in BIGTT-AIR, and 0.27–0.51 absolute
difference in BIGTT-sensitivity index, respectively.
Genotyping Genotyping of the 32 variants in 6,039 Danish
individuals was performed using KASPar SNP genotyping
(KBioscience, Hoddesdon, UK). The genotype distributions
for 31 of the variants obeyed Hardy–Weinberg equilibrium
in the population-based Inter99 study (p>0.0016). The
MTIF3 rs4771122 variant was slightly out of Hardy–
Weinberg equilibrium (p=0.0003). All 32 variants passed
quality control with an average mismatch rate of 0.10%
(maximum 0.66%) and an average success rate of 96.3%
(minimum 95.3%) estimated from regenotyping 454 ran-
dom duplicate samples. The number of genotyped SNPs in
Inter99 differs slightly from SNP to SNP because of
differences in genotyping success rate (95.3–97.1%).
Results
We evaluated the relationship of 18 previously BMI-
associated and 14 WHR-associated variants with glucose-
related metabolic traits in treatment-naive individuals from
the population-based Inter99 study sample.
Metabolic associations of variants previously shown to
relate to BMI Of the variants associated with BMI (Table 1),
the QPCTL rs2287019 BMI-associated C allele was
associated with a higher insulinogenic index of 7.4% per
risk allele (p=7.2×10−7). This association remained after
adjustment for BMI (p=4.0×10−7). Moreover, the same
variant was associated with a 5.6% increase in disposition
index (p=6.4×10−5), higher 30 min serum insulin levels (p=
1.4×10−6), higher AUC insulin (p=2.1×10−5), higher 2 h
plasma glucose levels (p=0.0073), and higher AUC glucose
(p=0.0022) (data not shown).
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The LRP1B rs2890652 BMI-increasing C allele showed
association at a Bonferroni-corrected level, with a 3.3%
decrease in insulin sensitivity per risk allele, as estimated
by HOMA-IR (p=0.0014), and a 2.2% reduction in
Matsuda index (p=0.0011) both when adjusted for sex
and age. The association was slightly weaker in a model
with adjustment for BMI (Table 1). rs2890652 C allele
furthermore was associated nominally with an elevated
fasting serum insulin level (3.0% p=0.0024, and p=0.015
after adjustment for BMI).
The remaining BMI-increasing alleles which only
showed nominally significant effects on the examined traits
included the TNNI3K rs1514175 A allele, the PRKD1
rs11847697 T allele and the SLC39A8 rs13107325 T allele.
These alleles showed somewhat higher insulinogenic index
(2.4% p=0.042, 7.1% p=0.019, and 6.2% p=0.025,
respectively), increased BIGTT-AIR (2.4% p=0.0036,
5.3% p=0.012, and 5.1% p=0.0094, respectively), and
increased disposition index (3.1% p=0.0057, 6.8% p=
0.023, and 4.7% p=0.049, respectively).
Metabolic associations of variants previously shown to
relate to WHR Results for the WHR-associated variants are
shown in Table 2 and ESM Tables 6 and 7. Of these
variants, only the LYPLAL1/SLC30A10 rs4846567 G allele
was associated at a Bonferroni-corrected level with im-
proved insulin sensitivity, with a 3.5% lower HOMA-IR per
risk allele in a model adjusted for BMI (p=0.0016).
Furthermore, this variant was also nominally associated
with decreased levels of fasting plasma glucose and fasting
serum insulin (0.5% p=0.036, 3.0% p=0.0041, respectively).
When analyses were conducted in a sex-stratified manner,
associations between this variant and the examined traits
were found only in women in models adjusted for BMI
(fasting plasma glucose, 0.9% [p=0.0026], fasting serum
insulin, 4.2% [p=0.0039], HOMA-IR, 5.2% [p=0.00086],
Matsuda index, 4.3% [p=0.0086], and disposition index,
5.9% [p=0.0017]). When calculated without adjustment for
BMI, all the associations disappeared, except for disposition
index (ESM Table 7).
Also, carriers of the VEGFA rs6905288 A allele
presented a nominally significant 2.6% increase in insulin
resistance per risk allele measured as HOMA-IR (p=0.013),
a 3.7% lower disposition index (p=0.004), and a 2.4%
increased fasting serum insulin level (p=0.012). When
stratified by sex, these associations were only found in
women. The per allele effects of HOMA-IR=3.7% (p=
0.00036), of fasting serum insulin=3.5% (p=0.0004) and
of Matsuda index=4.0% (p=2×10−4) reached Bonferroni-
corrected significance levels when the analyses did not
include adjustment for BMI (ESM Table 7).
A nominally increased level of fasting serum insulin of
2.8% per risk allele (p=0.0034) and a 2.6% higher HOMA-
IR (p=0.0098) per risk allele, indicating insulin resistance,
was also found among carriers of the GRB14 rs10195252
T allele. However, these associations were only found in
men (fasting serum insulin, 3.6% [p=0.0094]) and
(HOMA-IR. 3.4% [p=0.021]) when sex-stratified analy-
ses were performed.
Finally, the NFE2L3 rs1055144 T allele showed nomi-
nally significant lower levels of fasting plasma glucose of
0.7% per risk allele (p=0.0097) and BIGTT-AIR of 2.8%
(p=0.0096). In sex-stratified analyses, a 1.0% lower level
of fasting plasma glucose was only found in men (p=
0.0084); however, fasting serum insulin levels (p=0.0095)
and HOMA-IR (p=0.021) were 4.5% and 4.2% higher,
respectively, in women.
Combined effect of variants The combined effect of the
BMI risk variants and WHR risk variants was examined on
measures of glucose homeostasis in treatment-naive indi-
viduals from the Inter99 cohort. These analyses clearly
showed that previously GWAS-identified variants were also
associated with increased BMI (effect size, 0.01; 95% CI
0.004, 0.02; p=0.0014, Fig. 1) and increased WHR
(women: effect size, 0.006; 95% CI 0.003, 0.009; p=
0.0005; men: effect size, 0.003; 95% CI 0.0009, 0.006; p=
0.009; Figs 2 and 3, respectively) in the present study
population. Analyses of the combined effect of BMI genetic
variants showed association with several measures of
glucose homeostasis; however, these results were not
corrected for multiple testing and should therefore be
validated in independent studies. Variants associated with
increased BMI also associated with an increased disposition
index (0.03 [0.007, 0.06], p=0.01), which is a measure of
the insulin secretion in relation to the levels of insulin
resistance. Furthermore, the combined effect of the BMI
variants associated with a 3% (95% CI 0.8, 5) decrease in
fasting serum insulin (p=0.006) and increased insulin
sensitivity: a 3% (95% CI 0.7, 5) decrease in HOMA-IR
(p=0.01) and a 3% (95% CI 0.9, 5) increase in Matsuda
index (p=0.005).
For WHR variants, association with measures of glucose
homeostasis was only found in women. WHR variants
associated with a 3% (0.4–5) increase in fasting serum insulin
(p=0.02), a 3% (0.7–6) increase in HOMA-IR (p=0.01), and
a 4% (1–7) decrease in disposition index (p=0.008).
Discussion
By running large meta-analyses and extensive replication
studies, the third wave of GWAS of adiposity-related traits
has identified 14 variants associated with WHR and 18
variants associated with BMI. In the current random sample
of the Danish adult population, we aimed to elucidate the
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impact of these variants on OGTT-based measures of
insulin sensitivity and beta cell function in non-diabetic
individuals, to possibly clarify the interplay between body
composition and glucose homeostasis caused by these
variants.
When the effect of the combined BMI risk variants and
the combined WHR risk variants on measures of glucose
homeostasis was evaluated, it appeared that these measures
of body composition have different collective effects on
glucose metabolism. Variants associating with an increased
WHR appeared on the whole to reduce the ability of beta
cells to produce insulin when estimated in relation to the
ambient level of insulin resistance. The effects for WHR
risk variants were further investigated in men and women
separately, and the effects of WHR-associated loci on beta
cell capacity were only seen in women. In contrast, the
examined variants associating with increased BMI collec-
tively led to an increased beta cell capacity. This may be a
result of our study design, which included people who were
overweight or obese but were still normoglycaemic.
The outcome of the single-variant analyses showed,
however, that various adiposity-associated loci affect
measures of insulin release and insulin sensitivity differ-
ently. For instance, we found that the QPCTL C allele was
associated at a Bonferroni-corrected level with higher
values of insulinogenic index and disposition index,
whereas the LRP1B rs2890652 C allele showed association
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Fig. 3 Combined effects of WHR variants on measures of glucose
homeostasis in 2,404 women from the population-based Inter99
cohort. Only women with a genotype for all investigated variants
were included in the analyses of the combined effect (631 of the 3,035
individuals were excluded, leaving 2,404 individuals in this study).
Black horizontal line, non-significant effect size; grey line, significant
effect size (p<0.05)
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Fig. 2 Combined effects of WHR variants on measures of glucose
homeostasis in 2,387 men from the population-based Inter99 cohort.
Only men with a genotype for all investigated variants were included
in the analyses of the combined effect (617 of the 3,004 individuals
were excluded, leaving 2,387 individuals in this study). Black
horizontal line, non-significant effect size; grey line, significant effect
size (p<0.05)
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Fig. 1 Combined effects of BMI variants on measures of glucose
homeostasis in 4,588 individuals of both sexes from the population-
based Inter99 cohort. Only individuals with a genotype for all
investigated variants were included in the analyses of the combined
effect (1,451 of the 6,039 individuals were excluded, leaving 4,588
individuals in this study). Black horizontal line, non-significant effect
size; grey line, significant effect size (p<0.05)
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with decreased insulin sensitivity. Both of these alleles
represent loci that associate with increased levels of BMI.
The QPCTL rs2287019 is in high linkage disequilibrium
with variants in GIPR, which have previously been shown
to associate with beta cell function [14]. Supporting this
observation, we found that the QPCTL variant associated
with increased disposition index.
The BMI-associated variant in the LRP1B locus was
associated with more than one glucose homeostatic
measure after correction for multiple testing, whereas
TNNI3K, PRKD1 and SLC39A8 variants after Bonferroni
adjustment were associated with more homeostatic meas-
ures only at a nominal significance level. TNNI3K encodes
a cardiac troponin I-interacting kinase with no known
relation to glucose regulation. The same holds for PRKD1,
which encodes an uncharacterised protein kinase. Howev-
er, SLC39A8 is a member of the SLC39 family of solute-
carrier genes, which show structural similarities to zinc
transporters. Owing to the relationship between insulin
secretion and zinc metabolism in the beta cell, the
association with estimates of insulin release is not
surprising [15]. LRP1B belongs to the LDL receptor gene
family and therefore encodes a protein involved in
metabolism [16].
On the whole, we did not observe any major effect of
variants reported to associate with BMI on the fasting level
of plasma glucose. This may indicate that, despite an
increased requirement of insulin because of increased
adiposity, the beta cells of variant carriers are capable of
compensating for the relative and modest decrease in
insulin sensitivity, which is in line with the observations
from the combined analyses.
Of the variants associated with WHR, LYPLAL1/
SLC30A10 rs4846567 G allele associated after Bonferroni
correction with lower HOMA-IR, indicating increased
insulin sensitivity. In addition, decreased fasting levels of
glucose and insulin and increased HOMA-IR were seen in
women. These effects of variants that have been found to
associate with increased WHR are obviously unexpected.
In contrast, there are several pieces of evidence for the
insulin resistance of both male and female carriers of the
VEGFA rs6905288 A allele, male carriers of the GRB14 T
allele and female carriers of the NFE2L3 rs1055144 T
allele, findings that can be expected from the associations
of these risk alleles with increased WHR. However, only in
female carriers did the association of the VEGFA rs6905288
A allele with insulin resistance reach statistical significance
at a Bonferroni-corrected level.
All traits examined, including fasting plasma glucose,
showed an association with one or more variants that were
previously reported to associate with WHR.
We found that women, but not men, who carried the
VEGFA rs6905288 A allele showed a Bonferroni-corrected
association with decreased insulin sensitivity without
adjustment for BMI. This association was still evident in
models with BMI adjustment, pointing to a direct,
adiposity-independent effect on insulin action. The protein
encoded by VEGFA is known to be involved in adipo-
genesis, and raised levels of serum VEGFA have previously
been shown to be associated with overweight and obesity
[17, 18]. A German study of 1,578 non-diabetic individuals
reported that a variant (rs9472138 T allele) in VEGFA was
associated with increased insulin secretion [19]. These
findings make the VEGFA encoded protein a potential
candidate in the pathogenesis of insulin resistance and
adiposity.
Variants nominally associated with fasting plasma
glucose included NFE2L3 and LYPLAL1. For NFE2L3,
the signal was strongest in men, and this sex orientation is
concordant with the GIANT study, where the variant
showed one of the strongest associations with WHR in
men [5]. In a previous study [20], the variant near
LYPLAL1 was only found to associate with WHR in
women, and the sex relatedness was confirmed in analysis
of traits of glucose homeostasis. Because of our limited
knowledge of the functions of the nearby genes, LYPLAL1
and NFE2L3, we are unable to explain the biological
mechanisms behind these associations. The sex-specific
effect of LYPLAL1 is in line with a previous meta-analysis
of 16 GWAS (n=38,580) and a follow-up of 70,689
individuals [20] in which variation in LYPLAL1 showed a
sex-specific association with WHR. However, the T allele
of rs4846567, which, in the previous study, associated with
increased WHR, was associated with increased insulin
sensitivity in genetic models adjusted for BMI in the
present study. Also, the A allele of the variant located in the
vicinity of VEGFA was associated with increased WHR in
the GIANT study [5]; however, in the present study, the
same variant was associated with increased insulin sensi-
tivity independently of BMI. We have no obvious interpre-
tation of this finding other than that, in the present study,
we excluded individuals with known diabetes and by doing
so may have selected individuals possessing adaptive
mechanisms to cope with the projected adiposity-elicited
impairment of insulin sensitivity.
We note that a limitation of our explorative study is the
fact that we only corrected for the number of variants
analysed, without correcting for the different, but inter-
related, metabolic traits that we investigated. This limitation
will obviously increase the risk of type I errors.
In conclusion, our correlative findings from analysing
single-locus data suggest that some variation in validated
BMI- and WHR-associated loci are related to either
increased or decreased insulin sensitivity and therefore
potentially to metabolically healthy or metabolically un-
healthy subsets of obesity. However, when analysed
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collectively, variants associated with an increased WHR
appeared to reduce insulin release, and variants associated
with increased BMI appeared collectively to lead to an
increase in insulin release. Therefore, more in-depth
physiological studies are needed to disentangle how single
adiposity-associated loci and combined adiposity-
associated loci, respectively, affect insulin sensitivity and
insulin release.
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